
Panelists discuss how to effectively manage plaque psoriasis in a 55-year-old man by evaluating and potentially combining topical treatments with systemic therapies for optimal disease control.

Panelists discuss how to effectively manage plaque psoriasis in a 55-year-old man by evaluating and potentially combining topical treatments with systemic therapies for optimal disease control.

Panelists discuss how to develop tailored treatment approaches for a 34-year-old African American woman with plaque psoriasis, focusing on exploring nonsystemic options that consider her specific demographic and clinical profile.

Panelists discuss how to optimize plaque psoriasis treatment in a 32-year-old man, with a specific focus on addressing genital plaques to enhance patient comfort and improve overall treatment outcomes.

Benjamin Lockshin, MD, FAAD, discussed combining biologics with topical innovations like tapinarof and roflumilast to address plaque psoriasis treatment gaps.